CXCR4 and cancer: In recent years, CXCR4 has emerged as a potential target for cancer treatment with a particular focus on cancer stem cells that are regarded as chemotherapy-resistant (14–17) and several CXCR4 antagonists have shown promising therapeutic effects in first studies (18–20).